India invites bids for privatisation of Indian Medicines Pharmaceutical
Interested buyers in Indian Medicines Pharmaceutical should submit initial bids to the government by Oct. 15, according to the government document.
New Delhi: India has invited bids for the privatisation of Indian Medicines Pharmaceutical Corporation, the government said on Thursday.
It plans to sells its 98.1% stake in the company that makes alternative medicines, according to a government document. The remaining 1.89%, held by Kumaon Mandal Vikas Nigam Ltd., a firm owned by the northern state of Uttarakhand, will also be offloaded through the transaction.
The government previously tried to sell Indian Medicines Pharmaceutical in 2019. Stake sales in other state-owned firms such as BEML and Shipping Corp of India, announced in 2019, have also been hit by several delays.
Interested buyers in Indian Medicines Pharmaceutical should submit initial bids to the government by Oct. 15, according to the government document.
The company has reported a 205% jump in profit after tax in 2021/22 to 337.6 million rupees ($4.08 million). Its revenue from operations rose to 2.6 billion rupees in 2021/22 from 1.6 billion rupees the previous year.
Read also: Pfizer, BioNTech receive positive CHMP opinion for Omicron XBB.1.5-adapted COVID vaccine in EU
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd